The sharp decline in Intuitive Surgical today appears primarily driven by mounting concerns regarding procedure volume growth and the potential for a conservative update in its upcoming quarterly report. As the leader in robotic-assisted surgery, the market maintains exceptionally high expectations for the company’s utilization rates. Recent data points suggesting a deceleration in elective procedure growth across certain geographic regions have sparked fears that the post-pandemic surgical boom may be reaching a point of saturation, leading to a de-risking move by institutional investors.

Adding to the downward pressure is the evolving competitive landscape within the med-tech sector. Several large-scale competitors are making…